Completed PHASE4 INTERVENTIONAL 1-arm NCT01586013

the Effect Site Equilibration Time of Propofol is Age Dependant (ke0agedep)

Importance of Age as Covariable in the Requirements to Determine the Drug Plasma -Site Effect Equilibration Time for TCI Propofol Pharmacokinetic Models

Sponsor: Universidad del Desarrollo

Conditions Healthy

Interventions evaluation of propofol effect using BIS

Updated 6 times since 2017 Last updated: Apr 25, 2012 Started: Oct 31, 2010 Primary completion: Aug 31, 2011 Completion: Aug 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Healthy and is currently completed. Universidad del Desarrollo leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Oct 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universidad del Desarrollo

Data source: Universidad del Desarrollo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Santiago, Chile